Advertisement

Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD

Published:December 24, 2022DOI:https://doi.org/10.1016/j.dld.2022.12.004

      Abstract

      Background

      The Lyon Consensus proposed a hierarchical approach to GERD diagnosis based on conventional and new impedance-pH metrics, namely acid exposure time (AET), number of reflux episodes, post-reflux swallow-induced peristaltic wave (PSPW) index, and mean nocturnal baseline impedance (MNBI).

      Aims

      To define the value of conventional and new impedance-pH parameters as predictors of response to label-dose PPI in typical GERD.

      Methods

      Consecutive adult patients with typical esophageal symptoms were prospectively studied with impedance-pH monitoring and treated with 8-week label-dose PPI. At the end of the PPI course, symptoms response was assessed.

      Results

      Among 255 patients who entered the study, 168 (65.9%) reported symptom remission. At ROC analysis, both MNBI and PSPW index were significantly associated to PPI responsiveness with AUC of 0.783 and 0.801, respectively. Cut-off values of 1747Ω for MNBI and 50% for PSPW index were identified as discriminators between response and non-response to label-dose PPI. At multivariate analysis, MNBI, PSPW index, and AET >6% were efficient predictors of PPI responses (OR 3, 5.4 and 2.3, respectively). Number of reflux episodes did not predict PPI response.

      Conclusions

      The novel MII-pH variables together with pathological are highly predictive of response of the typical GERD syndrome to label-dose PPI.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vakil N.
        • van Zanten S.V.
        • Kahrilas P.
        • et al.
        The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.
        Am J Gastroenterol. 2006; 101: 1900-1920
        • Kahrilas P.J.
        • Shaheen N.J.
        • Vaezi M.F.
        American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.
        Gastroenterology. 2008; 135: 1392-1413
        • Aziz Q.
        • Fass R.
        • Gyawali C.P.
        • et al.
        Functional esophageal disorders.
        Gastroenterology. 2016; 150: 1368-1379
        • Gyawali C.P.
        • Kahrilas P.J.
        • Savarino E.
        • et al.
        Modern diagnosis of GERD: the Lyon consensus.
        Gut. 2018; 67: 1351-1362
        • Ghisa M.
        • Barberio B.
        • Savarino V.
        • et al.
        The Lyon consensus: does it differ from the previous ones?.
        J Neurogastroenterol Motil. 2020; 26: 311-321
        • Sifrim D.
        • Roman S.
        • Savarino E.
        • et al.
        Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world.
        Gut. 2020; https://doi.org/10.1136/gutjnl-2020-322627
        • Frazzoni M.
        • de Bortoli N.
        • Frazzoni L.
        • et al.
        Impedance-pH monitoring for diagnosis of reflux disease: new perspectives.
        Dig Dis Sci. 2017; 62: 1881-1889
        • Savarino E.
        • Bredenoord A.J.
        • Fox M.
        • et al.
        Advances in the physiological assessment and diagnosis of GERD.
        Nat Rev Gastroenterol Hepatol. 2017; 14: 665-676
        • Ribolsi M.
        • Savarino E.
        • Rogers B.
        • et al.
        High-resolution Manometry determinants of refractoriness of reflux symptoms to proton pump inhibitor therapy.
        J Neurogastroenterol Motil. 2020; 26: 447-454
        • Ribolsi M.
        • Gyawali C.P.
        • Savarino E.
        • et al.
        Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients.
        Neurogastroenterol Motil. 2020; 32: e13752
        • Rogers B.D.
        • Rengarajan A.
        • Mauro A.
        • et al.
        Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows.
        Neurogastroenterol Motil. 2020; 32: e13736
        • Rengarajan A.
        • Savarino E.
        • Della Coletta M.
        • et al.
        Mean nocturnal baseline impedance correlates with symptom outcome when acid exposure time is inconclusive on esophageal reflux monitoring.
        Clin Gastroenterol Hepatol. 2019; https://doi.org/10.1016/j.cgh.2019.05.044
        • Ribolsi M.
        • Savarino E.
        • Rogers B.
        • et al.
        Patients with definite and inconclusive evidence of reflux according to Lyon consensus display similar motility and esophagogastric junction characteristics.
        J Neurogastroenterol Motil. 2021; 27: 565-573
        • Frazzoni L.
        • Frazzoni M.
        • De Bortoli N.
        • et al.
        Application of Lyon consensus criteria for GERD diagnosis: evaluation of conventional and new impedance-pH parameters.
        Gut. 2021; 71: 1062-1067
        • Gyawali C.P.
        • Tutuian R.
        • Zerbib F.
        • et al.
        Value of pH impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management.
        Gastroenterology. 2021; 161: 1412-1422
        • Patel A.
        • Wang D.
        • Sainani N.
        • Sayuk G.S.
        • Gyawali C.P.
        Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.
        Aliment Pharmacol Ther. 2016; 44: 890-898
        • Rengarajan A.
        • Savarino E.
        • Della Coletta M.
        • et al.
        Mean nocturnal baseline impedance correlates with symptom outcome when acid exposure time is inconclusive on esophageal reflux monitoring.
        Clin Gastroenterol Hepatol. 2020; 18: 589-595
        • Frazzoni M.
        • Manta R.
        • Mirante V.G.
        • et al.
        Esophageal chemical clearance is impaired in gastro-esophageal reflux disease: a 24h impedance-pH monitoring assessment.
        Neurogastroenterol Motil. 2013; 25: 399-406
        • Ribolsi M.
        • Frazzoni M.
        • Marabotto E.
        • et al.
        Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon consensus.
        Aliment Pharmacol Ther. 2021; 54: 412-418
        • Frazzoni M.
        • Frazzoni L.
        • Tolone S.
        • et al.
        Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
        Am J Gastroenterol. 2018; 113: 670-676
        • Frazzoni M.
        • Frazzoni L.
        • Ribolsi M.
        • et al.
        Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting.
        Neurogastroenterol Motil. 2021; 33: e14085
        • Ribolsi M.
        • Luca Guarino M.P.
        • Balestrieri P.
        • et al.
        The results from up-front esophageal testing predict proton pump inhibitor response in patients with chronic cough.
        Am J Gastroenterol. 2021; 116: 2199-2206
        • Ribolsi M.
        • Savarino E.
        • De Bortoli N.
        • et al.
        Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
        Aliment Pharmacol Ther. 2014; 40: 966-973
        • de Bortoli N.
        • Martinucci I.
        • Savarino E.
        • et al.
        Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
        Clin Gastroenterol Hepatol. 2015; 13 (1082-8.e1)
        • Savarino E.
        • Pohl D.
        • Zentilin P.
        • et al.
        Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.
        Gut. 2009; 58: 1185-1191
        • Roman S.
        • Gyawali C.P.
        • Savarino E.
        • et al.
        Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group.
        Neurogastroenterol Motil. 2017;
        • Sifrim D.
        • Zerbib F.
        Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
        Gut. 2012; 61: 1340-1354
        • Ribolsi M.
        • Emerenziani S.
        • Petitti T.
        • et al.
        Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responders to proton pump inhibitors.
        Dig Liver Dis. 2012; 44: 549-554
        • Savarino E.
        • de Bortoli N.
        • Bellini M.
        • et al.
        Practice guidelines on the use of esophageal manometry - a GISMAD-SIGE-AIGO medical position statement.
        Dig Liver Dis. 2016; 48: 1124-1135
        • Yadlapati R.
        • Kahrilas P.J.
        • Fox M.R.
        • et al.
        Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0.
        Neurogastroenterol Motil. 2021; 33: e14058
        • Gyawali C.P.
        • Rogers B.
        • Frazzoni M.
        • et al.
        Inter-reviewer variability in interpretation of ph-impedance studies: the Wingate consensus.
        Clin Gastroenterol Hepatol. 2020; s1542-3565: 31230-31231
        • Savarino E.
        • Frazzoni M.
        • Marabotto E.
        • et al.
        A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring.
        Dig Liver Dis. 2020; 52: 966-980
        • Weusten B.L.
        • Roelofs J.M.
        • Akkermans L.M.
        • et al.
        The symptom-association probability: an improved method for symptom analysis of 24-h esophageal pH data.
        Gastroenterology. 1994; 107: 1741-1745
        • Tolone S.
        • de Cassan C.
        • de Bortoli N.
        • et al.
        Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
        Neurogastroenterol Motil. 2015; 27: 1175-1182
        • Ribolsi M.
        • Perrone G.
        • Caviglia R.
        • et al.
        Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparison between light and electron microscopy analysis.
        Dig Liver Dis. 2009; 41: 9-14
        • Slaughter J.C.
        • Goutte M.
        • Rymer J.A.
        • et al.
        Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.
        Clin Gastroenterol Hepatol. 2011; 9: 868-874
        • de Bortoli N.
        • Martinucci I.
        • Savarino E.
        • et al.
        Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?.
        Neurogastroenterol Motil. 2014; 26: 28-35
        • Frazzoni M.
        • Frazzoni L.
        • Ribolsi M.
        • et al.
        Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.
        Aliment Pharmacol Ther. 2022; 55: 1423-1430